Efficacy and Safety of Triple Drug Fixed-Dose Combination of Telmisartan, Amlodipine and Hydrochlorthiazide in the Management of Hypertension

Authors

  • Faruqui A Arif Health Care Center, NSR Road, Saibaba Colony, Coimbatore-11, Tamil Nadu
  • A Amlaselvam Health Care Center, NSR Road, Saibaba Colony, Coimbatore-11, Tamil Nadu
  • Renuka Sriram Health Care Center, NSR Road, Saibaba Colony, Coimbatore-11, Tamil Nadu

DOI:

https://doi.org/10.3329/jom.v16i1.22383

Keywords:

Diastolic, Systolic, Blood Pressure, Hypertension, Triple drug fixed dose combination

Abstract

Effective BP control is far away from reality in many patients in spite of advancements in many classes of antihypertensive drug therapy. Use of triple drug combination in the management of hypertension have already been established, however this study was conducted to evaluate the efficacy and safety of triple drug fixed dose combination of Telmisartan 40 mg, Amlodipine 5 mg and Hydrochlorothiazide 12.5mg. 69 hypertensive patients with seating cuff systolic blood pressure e 160 mmHg and diastolic blood pressure e100 mmHg were enrolled in the study. Patients were prescribed to take triple drug fixed dose combination for 120 days. Patients were evaluated on 30th, 60th and 120th days of treatment. There was statistically significant (p<0.0001) decrease in systolic blood pressure from baseline to 30th, 60th and 120th day of treatment mean±SD (166±18.6 mmHg vs.147±16.1, 137±14.7 and 130±13.9 mmHg) respectively. Similar to SBP, decrease in DBP was highly significant (p<0.0001) from the baseline to the 30th, 60th and 120th day of treatment (104±11.5 mmHg vs. 93.7±12.3, 89±10.2 and 84.5±8.98 mmHg respectively). Moreover at the end of the study period of 120 days 85.7% and 87.8% patients of age group >60 years and <60 years respectively achieved the JNC VIII recommended goal. This triple drug fixed dose combination of Telmisartan, Amlodipine and hydrochlorothiazide was found to be effective and safe option for the optimal management of hypertension.

DOI: http://dx.doi.org/10.3329/jom.v16i1.22383

J MEDICINE 2015; 16 : 18-22

Downloads

Download data is not yet available.
Abstract
625
PDF
358

Downloads

Published

2015-02-24

How to Cite

Arif, F. A., Amlaselvam, A., & Sriram, R. (2015). Efficacy and Safety of Triple Drug Fixed-Dose Combination of Telmisartan, Amlodipine and Hydrochlorthiazide in the Management of Hypertension. Journal of Medicine, 16(1), 18–22. https://doi.org/10.3329/jom.v16i1.22383

Issue

Vol. 16 No. 1 (2015)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).